Moderna working on combination COVID-19 booster & flu shot

Moderna says it is successful the process of processing a single-shot vaccine that could service arsenic a COVID-19 booster changeable and a flu shot.

In a press release Thursday touting its 5th yearly "R&D Day," Moderna said it had respective caller mRNA vaccines successful development, including 1 that combines a flu changeable and a COVID-19 vaccine booster.

The institution did not accidental however acold on the improvement of the changeable was oregon erstwhile it could statesman Phase 1 trials.

"I americium arrogant of the advancement that the Moderna squad has made successful advancing our best-in-class mRNA pipeline portion addressing the planetary COVID-19 pandemic," Moderna CEO Stéphane Bancel said. "We judge our mRNA level tin lick the world's top wellness challenges, from diseases impacting millions, to ultra-rare diseases impacting dozens, to medicines personalized down to the idiosyncratic level."

The announcement comes arsenic the FDA considers granting support to Moderna's COVID-19 booster shot. In August, the White House recommended that each afloat vaccinated Americans question retired a booster starting the week of Sept. 20. However, reports bespeak that the FDA's support of Moderna's booster changeable might not travel until aboriginal October.

In the aforesaid property release, Moderna has developed 4 vaccine candidates that would service arsenic boosters against existent variants of concern, including the delta variant.